Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Kestra Medical Technologies (KMTS) Non-cash Items (2025 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Non-cash Items for 2 consecutive years, with $16.2 million as the latest value for Q1 2026.

Quarterly Non-cash Items changed N/A to $16.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $16.2 million through Jan 2026, changed N/A year-over-year, with the annual reading at $32.6 million for FY2025, N/A changed from the prior year.
Non-cash Items for Q1 2026 was $16.2 million at Kestra Medical Technologies, down from $47.3 million in the prior quarter.
The five-year high for Non-cash Items was $47.3 million in Q4 2025, with the low at $16.2 million in Q1 2026.